# OnCo record paper-espac-3-fluorouracil-vs-gemcitabine-adjuvant-neoptolemos-jama-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-espac-3-fluorouracil-vs-gemcitabine-adjuvant-neoptolemos-jama-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-espac-3-fluorouracil-vs-gemcitabine-adjuvant-neoptolemos-jama-2010" ;
  schema:name "ESPAC-3: adjuvant fluorouracil plus folinic acid versus gemcitabine after pancreatic cancer resection"@en ;
  schema:description "After surgery for pancreatic cancer, six months of gemcitabine gave the same survival as fluorouracil with folinic acid, about 23 months, with half as many serious side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-espac-3-fluorouracil-vs-gemcitabine-adjuvant-neoptolemos-jama-2010/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2010.1275>, <https://pubmed.ncbi.nlm.nih.gov/20823433/> ;
  schema:sameAs <https://doi.org/10.1001/jama.2010.1275> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Neoptolemos JP, Stocken DD, Bassi C, et al." ;
  onco:cancers <https://onco.cc/cancers/resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:trials <https://onco.cc/trials/espac-3/> ;
  onco:journals <https://onco.cc/journals/jama/> .